Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease
Related Experiment Video
Updated: Mar 20, 2026

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E
Published on: September 26, 2019
Ji Li1, Aito Ueno, Miriam Fort Gasia
1*Department of Medicine/Gastroenterology, University of Calgary, Calgary, Alberta, Canada;†Department of Gastroenterology, Peking Union Medical College Hospital, Beijing, China;‡Calgary Laboratory Services, Calgary, Alberta, Canada;§Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; and‖Department of Production Animal Health, Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
Insights
The T helper 1 (Th1)/T helper 2 (Th2) paradigm effectively distinguishes Crohn's disease (CD) from ulcerative colitis (UC) using specific immune cell markers. This classification also correlates with treatment response and disease activity in inflammatory bowel disease (IBD).
Area of Science:
- Immunology
- Gastroenterology
- Molecular Biology
Background:
- Differentiating between ulcerative colitis (UC) and Crohn's disease (CD), two forms of inflammatory bowel disease (IBD), is clinically challenging.
- Existing theories propose CD is T helper type 1 (Th1)-driven and UC is T helper type 2 (Th2)-driven, but this paradigm requires validation.
- Investigating lamina propria T helper cell subsets is crucial for understanding IBD pathogenesis and distinguishing between CD and UC.
Purpose of the Study:
- To evaluate the potential of lamina propria T helper cell subsets in distinguishing between Crohn's disease (CD) and ulcerative colitis (UC).
- To assess the correlation between T helper cell profiles and response to tumor necrosis factor inhibitor therapy in CD.
- To examine the relationship between T helper cell subsets and disease activity in patients with IBD.
Main Methods:
- Analysis of T helper cell subsets (Th1, Th2, Th17, Treg) using specific markers (interferon-γ, T-bet, interleukin-13, Gata3, IL-17, RORγt, FoxP3) in biopsies from 79 IBD patients and 20 controls.
- Utilization of receiver-operating characteristic (ROC) curves to determine the diagnostic accuracy of different marker combinations.
- Application of a derived discriminant equation to newly diagnosed IBD patients to validate its discriminating ability.
Main Results:
- Crohn's disease (CD) patients exhibited higher frequencies of Th1 cells (IFN-γ, T-bet) and lower frequencies of Th2 cells (IL-13, Gata3) compared to ulcerative colitis (UC) patients.
- A discriminant equation incorporating IFN-γ, T-bet, IL-13, and Gata3 demonstrated high diagnostic accuracy (AUC) for differentiating CD from UC.
- Gata3 cell levels were elevated in non-responders to tumor necrosis factor inhibitor therapy in CD, while IFN-γ levels correlated with disease activity in CD and UC.
Conclusions:
- The T helper 1 (Th1)/T helper 2 (Th2) immune response paradigm is a valid method for distinguishing between Crohn's disease (CD) and ulcerative colitis (UC).
- This Th1/Th2 classification is associated with therapeutic response to tumor necrosis factor inhibitors in CD patients.
- The Th1/Th2 balance also correlates with disease activity across different inflammatory bowel diseases (IBD).
Background:
Distinction between 2 forms of inflammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn's disease (CD), can be challenging. Aberrant mucosal immunity suggests that CD is a T helper type 1 cell (Th1)-driven disease, whereas UC as Th2-driven response. However, whether this paradigm truly distinguishes CD from UC is controversial. We aimed to clarify the discriminating potential of lamina propria Th subsets in patients with IBD.
Methods:
Biopsies from 79 patients with IBD and 20 healthy controls were collected for Th subsets analysis (Th1:interferon γ [IFN-γ], T-bet; Th2:interleukin 13 [IL-13], Gata3; Th17:IL-17, RORγt; Treg:FoxP3). The receiver-operating characteristic curves were constructed to assess the discriminating ability by calculating the area under the receiver-operating characteristic curve. The equation with the highest area under the receiver-operating characteristic curve was applied to newly diagnosed patients to evaluate discriminating ability.
Results:
Patients with CD showed increased IFN-γ or T-bet cells and decreased IL-13 or Gata3 cells compared with UC. A discriminant equation composed of 4 markers (IFN-γ, T-bet, IL-13, and Gata3) yielded the highest area under the receiver-operating characteristic curve. In 36 established CD or UC, the sensitivity, specificity, positive and negative predictive probabilities were 92.6%, 55.6%, 86.2%, and 71.4% and in 14 newly diagnosed patients were 100.0%, 42.9%, 63.6%, and 100.0%. Furthermore, Gata3 cells were increased in tumor necrosis factor inhibitor therapy nonresponders compared with responders in CD. IFN-γ cells were directly and inversely proportional to disease activity in patients with CD and UC, respectively.
Conclusions:
The Th1/Th2 paradigm can distinguish CD from UC and may be further associated with response to tumor necrosis factor inhibitor in CD and disease activity in patients with IBD.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Renewal of Intestinal Stem Cells
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Differentiation of Common Myeloid Progenitor Cells

